Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-06

Clinical Trial Update: A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing adapalene gel 0.3% with tretinoin emollient cream 0.05% for the treatment of photoaging has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene Gel 0.3% (adapalene)
  • Tretinoin Emollient Cream 0.05% (tretinoin)

Snippet

Sponsor: Galderma Brasil Ltda. | Conditions: Photoaging, Photodamage | Phase 3 | Status: COMPLETED